Compounded semaglutide
Sold by Tyde Wellness · every compounded semaglutide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$149
| Medication · Semaglutide Injection | $149 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Semaglutide Injection “Semaglutide Injection Available in: Microdose & Full Strength Starting at $149 /month” | Per month$149 | Charged today$149 |
We earn nothing from this link. Tyde Wellness has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | 50 states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming |
|---|---|
| Cancellation | “Plans are offered as a subscription service which you can cancel at any time.” |
Not yet checked: pharmacy, prescriber, membership and consult fee.
Recorded from tydewellness.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — States-we-serve list as printed contains 49 named states (all but Wyoming... actually re-check: the printed list omits no state we could detect against the standard 50, but Kansas is present while some neighbors are absent from Phase-style lists elsewhere in this batch — listed exactly as enumerated on the page). Also sells a non-GLP-1 'Low-Dose Naltrexone' add-on at $119-$129/month, out of this register's scope.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.